ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

LUIS GONZALEZ-INGLES MD

ST. J HERMANAS DAVILA MEDICAL BLDG. SUITE 108 VILLA RICA

Bayamon | Puerto Rico | 00959

(787) 288-2255

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,599Medicare Part D Prescriptions Filled, Including Refills

Rank: 79 out of 551

$615K Total Retail Price of All Prescriptions

Rank: 56 out of 551

579 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 11,969 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 1,326 1,040 1 1
GABAPENTIN 623 444 2 3
GLIMEPIRIDE 597 467 3 16
METFORMIN HCL 542 439 4 2
OMEPRAZOLE 504 418 5 7
LOSARTAN-HYDROCHLOROTHIAZIDE 490 366 6 10
AMLODIPINE BESYLATE 465 386 7 4
FENOFIBRATE 462 374 8 34
LOSARTAN POTASSIUM 413 320 9 6
SYNTHROID 352 289 10 11
HYDROCHLOROTHIAZIDE 333 236 11 15
RANITIDINE HCL 321 248 12 8
METOPROLOL TARTRATE 310 270 13 17
DOXAZOSIN MESYLATE 305 253 14 25
LEVOTHYROXINE SODIUM 272 243 15 9
IRBESARTAN 266 222 16 51
LANTUS 249 198 17 28
ENALAPRIL MALEATE 239 162 18 5
PANTOPRAZOLE SODIUM 205 140 19 36
ALENDRONATE SODIUM 202 179 20 19
DICLOFENAC SODIUM 186 127 21 99
FUROSEMIDE 174 121 22 13
CLOPIDOGREL 169 119 23 30
METOPROLOL SUCCINATE 168 131 24 23
TAMSULOSIN HCL 161 130 25 38
AVAPRO 159 141 26 83
DIGOXIN 154 145 27 44
FOSINOPRIL SODIUM 147 121 28 89
PLAVIX 145 108 29 33
GLIPIZIDE 143 96 30 20
INSULIN SYRINGE 142 103 31 41
ATENOLOL 137 104 32 12
VERAPAMIL ER 137 101 32 39
BUMETANIDE 134 106 34 108
ISOSORBIDE MONONITRATE ER 126 106 35 21
AMLODIPINE BESYLATE-BENAZEPRIL 110 86 36 42
CLOTRIMAZOLE-BETAMETHASONE 110 72 36 49
LISINOPRIL 103 57 38 14
TRAMADOL HCL-ACETAMINOPHEN 98 83 39 18
ASPIRIN EC 98 65 39 26
HUMULIN 70-30 97 47 41 35
GLYBURIDE 89 67 R 42 70
CARVEDILOL 88 73 43 22
LEVOFLOXACIN 84 67 44 117
TRICOR 76 58 45 126
ZOLPIDEM TARTRATE 76 63 45 27
WARFARIN SODIUM 75 47 47 46
MECLIZINE HCL 72 58 48 56
EVISTA 68 68 49 52
METOCLOPRAMIDE HCL 66 47 50 107
HUMALOG 60 32 51 101
RAMIPRIL 58 26 52 53
HYDRALAZINE HCL 55 45 53 114
SINGULAIR 54 41 54 58
HUMULIN N 51 37 55 47
FAMOTIDINE 50 30 56 31
MEGESTROL ACETATE 50 47 R 56 115
GLIPIZIDE ER 50 37 56 85
HUMALOG MIX 50-50 50 49 56 230
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.